Clinical Trial Update: "The Evaluation of Stimulant Withdrawal" [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating stimulant withdrawal was withdrawn; conditions include anxiety and relapse.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Substance Use Disorder

Snippet

Sponsor: Aaron J. Janowsky | Conditions: Anxiety, Relapse | Phase 2 | Status: WITHDRAWN